The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
Open accessAbstract
Blood samples were collected from 52 incident cases of histologically confirmed prostate cancer, an equal number of cases of benign prostatic hyperplasia (BPH) and an equal number of apparently healthy control subjects. The three groups were matched for age and town of residence in the greater Athens area. Steroid hormones, sex hormone-binding globulin, and insulin-like growth factor 1 (IGF-1) were measured in duplicate by radioimmunoassay in a specialized US centre. Statistical analyses were performed using multiple logistical regression. The results for IGF-1 in relation to prostate cancer and BPH were adjusted for demographic and anthropometric factors, as well as for the other measured hormones. There was no relation between IGF-1 and BPH, but increased values of this hormone were associated with increased risk of prostate cancer; an increment of 60 ng ml(-1) corresponded to an odds ratio of 1.91 with a 95% confidence interval of 1.00-3.73. There was also some evidence for an interaction between high levels of testosterone and IGF-1 in relation to prostate cancer. This finding suggests that, in addition to testosterone, IGF-1 may increase the risk of prostate cancer in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goustin, A. S., Leof, E. B., Shipley, G. D., & Moses, H. L. (1986) · PubMed · Cited by 530
COHEN, P., PEEHL, D. M., LAMSON, G., & ROSENFELD, R. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-401 · Cited by 355
Burgess, A. W. (1985) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1985.tb00868.x · Cited by 351
Burfeind, P., Chernicky, C. L., Rininsland, F., Ilan, J., & Ilan, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7263 · Cited by 238
Kanety, H. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.1.229 · Cited by 236
Pietrzkowski, Z. J., Mulholland, G., Gomella, L. G., Jameson, B. A., Wernicke, D., & Baserga, R. (1993) · PubMed · Cited by 236
Daughaday, W. H. (1990) · Endocrinology · doi:10.1210/endo-127-1-1 · Cited by 226
Risk of endometrial and breast cancer in patients with diabetes mellitus
Weiderpass, E., Gridley, G., Persson, I., Nyrén, O., Ekbom, A., & Adami, H.-O. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<360::aid-ijc9>3.0.co;2-w · Cited by 186
Self-citationWebster, N. J. G., Resnik, J. L., Reichart, D. B., Strauss, B. E., Haas, M., & Seely, B. L. (1996) · PubMed · Cited by 171
Angelloz-Nicoud, P. (1995) · Endocrinology · doi:10.1210/en.136.12.5485 · Cited by 167
Cited by
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Self-citationObesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
Self-citationRole of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Khandwala, H. M., McCutcheon, I. E., Flyvbjerg, A., & Friend, K. E. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0399 · Cited by 843
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Biology of Prostate-Specific Antigen
Balk, S. P., Ko, Y.-J., & Bubley, G. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.083 · Cited by 718
The role of carotenoids in the prevention of human pathologies
Tapiero, H., Townsend, D. M., & Tew, K. D. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.12.006 · Cited by 645
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
Kaaks, R., & Lukanova, A. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns200070 · Cited by 615
Cancer Chemoprevention by Carotenoids
Tanaka, T., Shnimizu, M., & Moriwaki, H. (2012) · Molecules · doi:10.3390/molecules17033202 · Cited by 589
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Self-citationAdlercreutz, H. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701612942 · Cited by 547
Insulin-like growth factors and cancer
Fürstenberger, G., & Senn, H.-J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00731-3 · Cited by 536
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
Al-Nasiry, S., Geusens, N., Hanssens, M., Luyten, C., & Pijnenborg, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem011 · Cited by 486
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
Juul, A. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00038-8 · Cited by 467
Chan, J. M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.14.1099 · Cited by 433
Stattin, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1910 · Cited by 404
Glycemic index in chronic disease: a review
Augustin, L., Franceschi, S., Jenkins, D., Kendall, C., & La Vecchia, C. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601454 · Cited by 390
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Moschos, S. J., & Mantzoros, C. S. (2002) · Oncology · doi:10.1159/000066230 · Cited by 371
Self-citationReporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease Associations
Little, J., Bradley, L., Bray, M. S., Clyne, M., Dorman, J., Ellsworth, D. L., Hanson, J., Khoury, M., Lau, J., O'Brien, T. R., et al. (2002) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a000179 · Cited by 370
Rodriguez, C., Freedland, S. J., Deka, A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0754 · Cited by 354
Zhou, J.-R., Gugger, E. T., Tanaka, T., Guo, Y., Blackburn, G. L., & Clinton, S. K. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.9.1628 · Cited by 343
Hormonal Predictors of Prostate Cancer: A Meta-Analysis
Shaneyfelt, T., Husein, R., Bubley, G., & Mantzoros, C. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.847 · Cited by 310
Self-citationPlatz, E. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2009 · Cited by 255
Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1
Nahum, A., Zeller, L., Danilenko, M., Prall, O. W. J., Watts, C. K. W., Sutherland, R. L., Levy, J., & Sharoni, Y. (2006) · European Journal of Nutrition · doi:10.1007/s00394-006-0595-x · Cited by 99
Metadata
- Authors
- Mantzoros, C., Tzonou, A., Signorello, L., Stampfer, M., Trichopoulos, D., & Adami, H.-O.
- Venue
- British Journal of Cancer
- Published
- 1997-11
- Volume
- 76
- Issue
- 9
- Pages
- 1115-1118
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2031169955
- Cited by
- 366
- References
- 15
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.